Effects of Health Behavioral Modification Program on Metabolic Diseases in Non-Government Organizations

Intarakamhang, Ungsinun
September 2011
Journal of US-China Medical Science;Sep2011, Vol. 8 Issue 9, p540
Academic Journal
The recent health screening for metabolic diseases in Thai workers, Bangkok reported that health behavior of workers aged 25-59 years were at risk overweight. Objectives: (1) To evaluate managing for health behavioral modification program (HBMP) of non-governmental organizations (NGOs), (2) to compare behavior change and biochemical indicators between before and after program, and study factors affecting program success and barrier to the program implementation. Materials and Methods: Totally, there were 8 HBMPs conducted by NGOs between May, 2009-January, 2010. A sample of 3414 participants who were at risk for metabolic diseases. The study instruments were developed based on CIPP Model to collect data during program from 3 groups of respondents, including 8 program leaders, 8 administrators of program leaders, and some participants and health behavior questionnaires for assessing behavior change from the sample. Results: Opinions on the context, input, process, and product (CIPP) were at the good to very good level in total among 3 groups of respondents; including program leaders, administrators of program leaders, and participants. In addition, the factors affecting program success were a budget from the National Health Security Office, high potential staff, awareness and willingness of participants, cooperation of participants, activities relevant to lifestyles of participants, provision of ongoing information, good relationship between program leaders and participants, motivation and rewards for participants. Barriers to the program implementation included participants drop out from the program due to work load, unawareness about their health problem, and insufficiency of budget. After participating in the program, health behaviors of the participants (in self-efficacy, self-regulation, and self-care) were statistically significantly higher than before their participation, with p-value at 0.05 level. The participants had demonstrated an improvement in some health indicators: BMI, systolic blood pressure, and waistline measurement. These indicators were statistically significantly lower in comparison with pre -intervention data, with p-value at 0.05 level. Conclusions: HBMPs conducted by NGOs were successful and effective at improved health behaviors and decreased in biochemical indicators.


Related Articles

  • Newborn screening. Murray, Sally // CMAJ: Canadian Medical Association Journal;10/25/2005, Vol. 173 Issue 9, p1022 

    Reports on a decision by Ontario to add tests for inherited metabolic disorders, as of October 2005. Number of tests being added by the province; Comparison between the number of diseases being screened in Ontario and in California.

  • Is compulsor overseas medical screening of migrants... Weekers, Jacqueline; Psych, Dipl // Public Health Reports;Sep/Oct97, Vol. 112 Issue 5, p396 

    Provides information on the medical services offered by the US International Organization for Migration (IOM) for prospective migrants. Main reason why resettlement countries impose mandatory medical screening; Limitations of medical screening test; Public health relevance of screening of...

  • HTA on neonatal screening for rare metabolic disorders faced misconceptions and blurred objectivity. Autti-Rämö, Ilona // Orphanet Journal of Rare Diseases;2012, Vol. 7 Issue Suppl 2, p1 

    An abstract of the article "HTA on neonatal screening for rare metabolic disorders faced misconceptions and blurred objectivity," by Ilona Autti-Rämö is presented.

  • Request these tests! Stine, Caitlin // Baby Talk;Oct2004, Vol. 69 Issue 8, p24 

    Explains the importance of genetic disorder tests to infants. Danger of metabolic disorder; Requirement of the test; Recommended Web sites.

  • A TEASPOON OF SUGAR. Chace, Donald H.; Chan, Y. Michael // Wellness Options;2005, Issue 19, p20 

    Provides information on the history and development of newborn screening. Metabolic disorders that have been discovered through newborn screening; Technological advancements for newborn screening; Disease that result from utilization of fatty acids by the body for energy.

  • Screening for familial hypercholesterolaemia. Kastelein, J J P // BMJ: British Medical Journal (International Edition);12/16/2000, Vol. 321 Issue 7275, p1483 

    Editorial. Focuses on medical advancements pertaining to familial hypercholesterolemia, a common lipid metabolism disorder. Low percentage of sufferers who are diagnosed at an early age; Number of people affected by the disorder; Effects of the disorder including increased risk of coronary...

  • Primary Hyperparathyroidism in Patients with Multiple Endocrine Neoplasia Type 1. Piecha, Grzegorz; Chudek, Jerzy; Więcek, Andrzej // International Journal of Endocrinology;2010, p1 

    Primary hyperparathyroidism may occur as a part of an inherited syndrome in a combination with pancreatic endocrine tumours and/or pituitary adenoma, which is classified as Multiple Endocrine Neoplasia type 1 (MEN-1). This syndrome is caused by a germline mutation in MEN-1 gene encoding a...

  • Study of the Knowledge of Inherited Metabolic Disorders among patients and their families in the Irish population. O'Shea, Rosie; Treacy, Eileen; Murphy, Anne Marie; Lynch, Sally Ann; Lambert, Deborah // Ulster Medical Journal;2008, Vol. 77 Issue 1, p73 

    Galactosaemia and Maple Syrup Urine Disease (MSUD) are recessively inherited conditions screened for by newborn screening in Ireland. Affected patients are followed at the National Centre for Inherited Metabolic Disease. We aimed to assess the degree of genetic knowledge imparted to families to...

  • Newborn Screening for Metabolic Diseases. Millington, David S. // American Scientist;Jan/Feb2002, Vol. 90 Issue 1, p40 

    Discusses several newborn screening techniques for metabolic diseases. Cause of metabolic diseases; Challenges of diagnosing metabolic diseases; Treatments for metabolic diseases; Information on the newborn testing method developed by the Duke Uni versity Medical Center.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics